VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5626AA: VAERS reports

20 VAERS reports list lot U5626AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2017-06-27 and 2019-04-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3352%
Neurological914%
General / Systemic (non-local)812%
Musculoskeletal58%
Cardiac / Cardiovascular46%
Respiratory23%
Gastrointestinal12%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts4
Florida2
Arizona2
Washington2
Texas1
Missouri1
Ohio1
Nevada1
District of Columbia1
Rhode Island1
Alabama1
California1

Reports by month received

2017-061
2017-078
2017-084
2017-092
2017-102
2017-121
2018-101
2019-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.